How psychedelic drugs could transform treatment of mental health problems
Drugs are bad... or are they? Razor examines the psychedelic revolution taking place in the fields of medicinal and psychological research, where it's proving to have a radical impact in the treatment of mental health conditions.
Emma Keeling talks to Rick Doblin from the Multidisciplinary Association for Psychedelic Studies, who has just published the results of a successful Phase 3 clinical trial using MDMA to treat war veterans with Post-Traumatic Stress Disorder (PTSD). We also hear from a reform activist whose own experience with depression was transformed by a psychedelic treatment.